

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| ALLUMIA VENTURES FUND IIIFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
2 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Daniel Galles | Slowing | Digital health, Healthcare services | 9 | 1 |
Categories of Allumia Ventures’s own portfolio companies, based on 5 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Allumia Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Hatteras Venture Partners | 1 | Wildflower Health |
| HLM Venture Partners | 1 | Aventura HQ |
| Lux Capital | 1 | Kyruus |
| Sonder Futures | 1 |
| Jeffery Stolte | Quiet | None listed | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| Gauss Surgical |
| SV Life Sciences | 1 | Spinal Kinetics |
A shared board seat: a company where filings name a Allumia Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.